Pharmavite LLC
14
2
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
1 terminated/withdrawn out of 14 trials
87.5%
+1.0% vs industry average
7%
1 trials in Phase 3/4
43%
3 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Assessing Two Coenzyme Q10 Products in Men and Women
Role: collaborator
Impact of Nutritional Supplementation on Sleep Quality
Role: lead
Vitamin D and Omega-3 Trial (VITAL)
Role: collaborator
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Role: collaborator
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
Role: lead
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Role: collaborator
Effect of a Nutritional Supplement on Mental Wellness in Adults
Role: lead
Effect of a Nutritional Supplement on Gut Microbiota in Adults
Role: lead
A Nutritional Supplement on Vasomotor Symptoms in Women
Role: lead
Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement
Role: collaborator
Bioavailability of EPA + DHA in a SMEDS Formulation
Role: collaborator
Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)
Role: collaborator
A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melatonin in Healthy Adults
Role: lead
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
Role: collaborator
All 14 trials loaded